Amplia Therapeutics Limited

INNMF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income$0-$5-$6-$4
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0-$1
Stock-Based Comp.$0$0$0$0
Change in WC-$1-$2$1-$1
Other Non-Cash-$6$1-$0$1
Operating Cash Flow-$7-$5-$5-$4
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$0-$0
Investing Cash Flow-$0-$0-$0-$0
Financing Activities
Debt Repay.-$2-$1-$0$2
Stock Issued$17$0$0$16
Stock Repurch.-$1$0$0-$1
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0$0
Financing Cash Flow$14-$1-$0$17
Forex Effect$0$0$0-$0
Net Chg. in Cash$7-$6-$5$13
Supplemental Information
Beg. Cash$3$9$15$2
End Cash$11$3$9$15
Free Cash Flow-$7-$5-$5-$4
Amplia Therapeutics Limited (INNMF) Financial Statements & Key Stats | AlphaPilot